A judge in Oklahoma has denied Johnson & Johnson’s motion to dismiss the state’s case accusing it of contributing to the opioid epidemic. J&J has said the lawsuit is making it a “scapegoat” for the public health crisis. Purdue Pharma and Teva Pharmaceuticals have both settled with the state. (CNN)

A federal judge struck down the rule requiring drugmakers to disclose list prices in TV ads just hours before it was supposed to go into effect. The judge said the Department of Health and Human Services did not have the authority to make the rule. (MM&M)

Novartis is planning to sell its generic epinephrine shot in pharmacies amid the EpiPen shortage. There has been a shortage of EpiPen, made by Mylan, for more than a year due to manufacturing problems. A surge in demand for the shots typically takes place in the summer as parents prepare to send children with allergies back to school. (Reuters)

A lawsuit that could decide the fate of the Affordable Care Act has started the appeals process. The case was appealed after a Texas federal judge struck down the entire healthcare law in December. It could make its way to the Supreme Court before the 2020 election. (New York Times)

Microsoft has partnered with hospital chain Providence St. Joseph Health to build a high-tech hospital in Seattle. The facility would streamline electronic medical records and integrate technology like machine learning. (CNBC)